Based on these results, we suspected the patient had DM and measured autoantibodies specific to DM (Table 1), which yielded positive results for the antitranscriptional intermediary factor 1-γ (TIF1-γ) antibody, which is particularly positive in DM associated with malignancy. This evidence concerns the gene TRIM33 and dermatomyositis.